Han Ying
Director Técnico/Científico/I+D en IMMUNOTECH BIOPHARM LTD .
Perfil
Han Ying is the founder of Gene Corp., which was founded in 2021.
Dr. Ying is currently the Chief Executive Officer & Director at Gyre Therapeutics, Inc. since 2023 and the Chief Scientific Officer at Immunotech Biopharm Ltd.
Dr. Ying previously worked as a Director at Base Therapeutics.
Dr. Ying obtained a doctorate degree from Stanford University and completed undergraduate and graduate degrees from Peking University.
Cargos activos de Han Ying
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Han Ying.
| Empresas | Cargo | Fin |
|---|---|---|
Gene Corp.
 Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Fundador | - |
Formación de Han Ying.
| Stanford University | Doctorate Degree |
| Peking University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Retail Trade |
- Bolsa de valores
- Insiders
- Han Ying
